ID24439A - Penggunaan tiazolidindion untuk pengobatan hiperglikemia - Google Patents

Penggunaan tiazolidindion untuk pengobatan hiperglikemia

Info

Publication number
ID24439A
ID24439A IDW20000670A ID20000670A ID24439A ID 24439 A ID24439 A ID 24439A ID W20000670 A IDW20000670 A ID W20000670A ID 20000670 A ID20000670 A ID 20000670A ID 24439 A ID24439 A ID 24439A
Authority
ID
Indonesia
Prior art keywords
tiazolidindion
hyperglicemia
treatment
hyperglicemia treatment
Prior art date
Application number
IDW20000670A
Other languages
English (en)
Inventor
Robin E Buckingham
Stephen A Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID24439A publication Critical patent/ID24439A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20000670A 1997-10-13 1998-10-12 Penggunaan tiazolidindion untuk pengobatan hiperglikemia ID24439A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721692.3A GB9721692D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
ID24439A true ID24439A (id) 2000-07-20

Family

ID=10820481

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000670A ID24439A (id) 1997-10-13 1998-10-12 Penggunaan tiazolidindion untuk pengobatan hiperglikemia

Country Status (24)

Country Link
EP (1) EP1023057A1 (id)
JP (1) JP2001519383A (id)
KR (1) KR20010024482A (id)
CN (1) CN1281358A (id)
AP (1) AP1223A (id)
AU (1) AU9547198A (id)
BG (1) BG104405A (id)
BR (1) BR9815220A (id)
CA (1) CA2305289A1 (id)
CZ (1) CZ20001298A3 (id)
EA (1) EA200000418A1 (id)
GB (1) GB9721692D0 (id)
HR (1) HRP20000256A2 (id)
HU (1) HUP0003673A3 (id)
ID (1) ID24439A (id)
IL (1) IL135515A0 (id)
NO (1) NO20001897L (id)
OA (1) OA11519A (id)
PL (1) PL339804A1 (id)
SK (1) SK5322000A3 (id)
TR (1) TR200000957T2 (id)
UA (1) UA66809C2 (id)
WO (1) WO1999018944A1 (id)
YU (1) YU28700A (id)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
ES2237929T3 (es) * 1998-07-21 2005-08-01 Smithkline Beecham Plc Uso del activador de la asimilacion de glucosa rosiglitazona para reducir la apoptosis inducida por isquemia de celulas beta pancreaticas, celulas endoteliales y celulas neuronales.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
CA2305289A1 (en) 1999-04-22
KR20010024482A (ko) 2001-03-26
JP2001519383A (ja) 2001-10-23
AU9547198A (en) 1999-05-03
YU28700A (sh) 2003-10-31
IL135515A0 (en) 2001-05-20
BG104405A (en) 2000-12-29
OA11519A (en) 2004-02-09
BR9815220A (pt) 2000-11-14
CZ20001298A3 (cs) 2001-08-15
EP1023057A1 (en) 2000-08-02
NO20001897D0 (no) 2000-04-12
AP2000001788A0 (en) 2000-06-30
WO1999018944A1 (en) 1999-04-22
EA200000418A1 (ru) 2000-10-30
SK5322000A3 (en) 2000-09-12
AP1223A (en) 2003-11-13
GB9721692D0 (en) 1997-12-10
HUP0003673A3 (en) 2001-12-28
PL339804A1 (en) 2001-01-02
HUP0003673A2 (hu) 2001-10-28
TR200000957T2 (tr) 2000-08-21
HRP20000256A2 (en) 2000-12-31
UA66809C2 (uk) 2004-06-15
NO20001897L (no) 2000-06-09
CN1281358A (zh) 2001-01-24

Similar Documents

Publication Publication Date Title
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
NO983266D0 (no) Distribuert Behandling
DK0951447T3 (da) Vandbehandling
NO992806L (no) Terapeutiske midler
DE69524138D1 (de) Hautbehandlungsmittel
ID18679A (id) Penggunaan terapi lanjutan
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
EP0996433A4 (en) Methods for treatment of conditions associated with lactosylceramide
DE69807225D1 (de) Vliesstoffbehandlung
DE69833493D1 (de) Gewebe
ID21948A (id) Penggunaan 1-hidroksi-2piridon untuk pengobatan infeksi-infeksi kulit
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
IS4789A (is) Meðferðarefnasambönd
NO983263D0 (no) Distribuert behandling
ID24270A (id) Penghilang sumbatan keratotik
ID23437A (id) Penghilang sumbatan keratotik
ID24922A (id) Terapi kombinasi untuk pengobatan aids
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69812879D1 (de) Patientenliege
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID17383A (id) Penggunaan terbaru turunan turunan sistina
NO20000274D0 (no) Behandling av fluider
ID29414A (id) Pengobatan depresi
ID17459A (id) Unsur-unsur pengobatan
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose